- Dallas-Fort Worth recorded a nearly 6% year-over-year increase in life sciences job postings during the first half of 2026, according to Cushman & Wakefield.
- Pegasus Park, a 26-acre Dallas campus developed in 2021, has become the region’s central hub for biotech startups moving out of early-stage clinical space.
- Novartis and Stallion Labs are building new manufacturing facilities in Denton and Mansfield, signaling DFW’s life sciences sector is maturing beyond research into production.
Dallas-Fort Worth is positioning itself as a rising national player in life sciences, with a nearly 6% jump in sector job postings signaling real estate demand is following the capital. Cushman & Wakefield reported the year-over-year job posting increase for the first half of 2026 as part of its September life sciences update, according to Bisnow. Industry leaders discussed the momentum at Bisnow’s DFW Life Sciences Summit, held Wednesday at Dallas’s Pegasus Park.
Get Smarter About What Matters in Texas
Subscribe to our free newsletter covering the biggest commercial real estate stories across Texas — delivered in just 5 minutes.
How It Started
The region still trails established life sciences hubs like Boston and San Francisco. However, the shift has grown since 2019, according to Y’all Street Bio founder Brad Phelan.
Before Pegasus Park opened, DFW had little dedicated lab space. Most facilities were at UT Southwestern or in Fort Worth.
Lyda Hill Philanthropies and J. Small Investments changed that in 2021. They developed the 26-acre Pegasus Park campus into a central hub.
The campus gave biotech and life sciences companies a place to expand. Many of those firms emerged from the region’s research institutions.
Phelan said the industry still needs better access to capital. That remains especially important for early-stage innovators as the ecosystem matures.
The Details
Raising capital is now harder for life sciences companies than it has been in a decade. BMK Pharma founder Jay Bhaumik made the comment at the summit.
That funding squeeze has created an opening for DFW. The region offers a business-friendly regulatory environment and lower construction costs than many coastal markets.
DFW’s manufacturing footprint is expanding as a result. Swiss pharmaceutical company Novartis is building a radioligand therapy manufacturing facility in Denton.
India-based Stallion Labs is also developing a 200,000-square-foot headquarters campus in Mansfield.
Those projects could attract secondary manufacturers that support pharmaceutical development. Dallas Regional Chamber vice president Kelly Cloud said the region’s central U.S. location also gives it an edge.
DFW offers direct flights to either coast in about four hours. Cloud said that connectivity can help firms scale production.
Zooming Out
Capital is following the sector’s growth. Venture capital investment in life sciences rebounded nationally last year.
DFW ranked among the emerging markets with the biggest year-over-year gains, according to CBRE.
Local family offices have provided much of the early funding. Phelan said these investors often back companies before institutional investors step in.
That dynamic has helped several DFW life sciences firms get started. As they grow, some attract national institutional capital.
The local-capital advantage also reflects broader momentum in nearby submarkets. For example, Denton’s expansion shows how manufacturers are planting roots outside Dallas proper.
Why It Matters
The sector’s maturation matters for landlords and investors. It points to a coming wave of real estate demand beyond lab space.
Early-stage companies typically invest little in commercial real estate. However, Curve Biosciences CEO Ritish Patnaik said that is starting to change.
Many DFW firms are reaching an inflection point after strong Phase 2 and Phase 3 trial results. As a result, they will soon need manufacturing facilities.
They will also need office space for expanding commercial teams.
That shift reflects a broader trend in major U.S. markets. Healthcare and life sciences tenants are helping reshape demand for office space.
These tenants are increasingly filling space that other industries have left vacant.
What’s Next
Higher education partnerships should keep feeding the pipeline.
The University of Texas at Arlington and Texas A&M Engineering Experiment Station opened a biomanufacturing training and research hub at Pegasus Park late last year.
Cloud said no other U.S. market has a comparable resource.
Meanwhile, DFW continues to add population and has room to expand northward. Industry leaders expect the region to attract more early-stage startups.
They also expect more secondary manufacturers and commercial teams. These companies often follow once products clear clinical trials.
